IP Library Assignment 030539/0396
Patent Assignment
Reel/Frame 030539/0396

Assignment of Assignor's Interest

Recorded: 2013-06-04 Pages: 21
Assignors
MORTIMORE, MICHAEL
Executed: 2009-10-12
YOUNG, STEPHEN CLINTON
Executed: 2009-10-08
EVERITT, SIMON ROBERT LORRIE
Executed: 2009-10-07
KNEGTEL, RONALD
Executed: 2009-10-07
PINDER, JEANNE LOUISE
Executed: 2009-10-07
RUTHERFORD, ALISTAIR PETER
Executed: 2009-10-07
DURRANT, STEVEN
Executed: 2009-10-07
BRENCHLEY, GUY
Executed: 2009-10-07
CHARRIER, JEAN-DAMIEN
Executed: 2009-10-08
O'DONNELL, MICHAEL
Executed: 2013-04-10
Assignee
VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY STREET, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Property (1)
5-Cyano-4- (Pyrrolo [2,3B] Pyridine-3-Yl) -Pyrimidine Derivatives Useful as Protein Kinase Inhibitors
Patent: 8,530,489 →
Application: 13/477,663 →
Publication: US 2012/0309963
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest Jul 10, 2014
From: VERTEX PHARMACEUTICALS INCORPORATED; VERTEX PHARMACEUTICALS (SAN DIEGO) LLC
To: MACQUARIE US TRADING LLC
Reel/Frame 033292/0311 →
Release of Security Interest Oct 14, 2016
From: MACQUARIE US TRADING LLC
To: VERTEX PHARMACEUTICALS INCORPORATED; VERTEX PHARMACEUTICALS (SAN DIEGO) LLC
Reel/Frame 040357/0001 →